Presentation of biotech reports 2017/18 by vfa bio and BioM + overview of Staburo's Data Analytics solutions The vfa bio - the biotechnology advocacy group in the Association of Research-Based Pharmaceutical Companies - and BioM presented the current development of...

Team spirit, speed and strength. Qualities, which our clients normally value in biostatistics projects with us - we wanted to bring on the race track in the 2018 B2RUN in Munich. The 6.1 km long was scheduled to take place in the Olympic Park, with the finish in the...

Staburo goes Bioinformatics! We are very glad to welcome Dr. Janine Roy in our team. Janine is a bioinformatician by training, with an excellent education and broad working experience in the clinical, as well as the academic environment. She will support our clients...

We are very glad to welcome Ningfu Sun in our Munich team. Ningfu supports us in biostatistics & statistical programming. With Ningfu, we win a team member with an excellent education, great biostatistics and programming skills and significant project experience....

We invited clients, employees and friends to our summer party on 8 June 2018. There were many reasons to celebrate, such as the move to our new shiny office earlier this year, and the 10 years anniversary of our business plan seminar participation at unternehmerTUM....

Staburo poster presentation at PSI 2018 Staburo Managing Director Dr. Hannes Buchner will present the enhanced rank-preserving structural failure time method (eRPSFT), to adjust for treatment switching in 3-arm superiority trials. Meet Hannes personally at the PSI...

The Staburo Managing Directors Josef Hoefler and Roland Stieger had the opportunity to join the AGAH Annual Meeting in April 2018, here in Munich. The conference focused on how to prevent or predict adverse drug reactions in early phase drug development. The major...

Staburo at the Biometric Colloquium 2018 in Frankfurt Staburo participated in the 64th Biometric Colloquium 2018 in Frankfurt, the annual meeting of the German Region of the International Biometric Society (IBS-DR). The conference was hosted by the faculty of medicine...

Tumour growth over time Longitudinal Data, Joint Models, and Surrogate Endpoints for Survival Analysis   Tumour burden has been shown to be associated with clinical outcomes in many oncological indications. To explore the impact of treatment on tumour growth over...